Literature DB >> 8919822

A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene.

H Okamoto1, S Kobata, H Tokita, T Inoue, G D Woodfield, P V Holland, B A Al-Knawy, O Uzunalimoglu, Y Miyakawa, M Mayumi.   

Abstract

A second-generation method of genotyping hepatitis C virus (HCV) was developed by the polymerase chain reaction (PCR) with sense as well as antisense primers deduced from the core gene. HCV RNA specimens extracted from sera were reverse-transcribed and amplified with universal primers in the first round of PCR to obtain fragments of 433 base pairs representing nucleotides 319-751. In the second round of PCR, portions of PCR products were amplified separately with sense and antisense primers specific for each of the five common genotypes prevailing across the world, i.e., I/1a, II/1b, III/2a, IV/2b and V/3a. The specificity of the method was verified by a panel of 177 HCV isolates of various genotypes in the genetic groups 1-9. It allowed clear differentiation of genotype I/1a from II/1b which was not always accomplished by the previous method. When 501 sera from blood donors and hepatitis patients with HCV viremia from various countries were genotyped by the second-generation method, 478 (95.4%) were classified into the five genotypes. HCV RNA samples from 23 (4.6%) sera were not classifiable into any of the five common genotypes and, by sequence analysis, 22 were found to be of four genotypes in group 4 and one of genotype 1c in Simmond's classification.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8919822     DOI: 10.1016/0166-0934(95)01960-x

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  12 in total

1.  Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype 1b from other genotypes.

Authors:  L Krekulova; V Rehak; A E Wakil; E Harris; L W Riley
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Full-length genomic sequence of a hepatitis C virus genotype 2c isolate (BEBE1) and the 2c-specific PCR primers.

Authors:  H Nakao; H Okamoto; H Tokita; T Inoue; H Iizuka; G Pozzato; S Mishiro
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 3.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease.

Authors:  H L Tillmann; D F Chen; C Trautwein; V Kliem; A Grundey; A Berning-Haag; K Böker; S Kubicka; L Pastucha; W Stangel; M P Manns
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

5.  Genomic and phylogenetic analysis of hepatitis C virus isolates from argentine patients: a six-year retrospective study.

Authors:  J F Quarleri; B H Robertson; V L Mathet; M Feld; L Espínola; M P Requeijo; O Mandó; G Carballal; J R Oubiña
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

6.  Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia.

Authors:  D K Lvov; E I Samokhvalov; F Tsuda; N A Selivanov; H Okamoto; V M Stakhanova; I V Stakhgildyan; N V Doroshenko; T L Yashina; S N Kuzin; I A Suetina; P G Deryabin; L A Ruzaeva; V N Bezgodov; L A Firsova; S N Sorinson; S Mishiro
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method.

Authors:  P V Holland; J M Barrera; M G Ercilla; C F Yoshida; Y Wang; G A de Olim; B Betlach; K Kuramoto; H Okamoto
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

8.  Multiplex real-time reverse transcription-PCR assay for determination of hepatitis C virus genotypes.

Authors:  Linda Cook; KaWing Sullivan; Elizabeth M Krantz; Arthur Bagabag; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

9.  Disadvantages of peginterferon and ribavirin treatment in older patients with chronic hepatitis C: an analysis using the propensity score.

Authors:  Hirotoshi Ebinuma; Hidetsugu Saito; Shinichiro Tada; Nobuhiro Nakamoto; Tazuko Ohishi; Satoshi Tsunematsu; Naoki Kumagai; Kanji Tsuchimoto; Nobuhiro Tsukada; Yasutaka Inagaki; Yoshinori Horie; Masahiko Takahashi; Kazuhiro Atsukawa; Yukishige Okamura; Takanori Kanai; Toshifumi Hibi
Journal:  Hepatol Int       Date:  2011-09-10       Impact factor: 6.047

Review 10.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.